Our forum is experiencing technical difficulties with comments being displayed. We apologize for the inconvience.

GCS Resources - Page 2 of 4 - The GCS Project

Sample letter for your Physician

Please use this sample letter to take to your physician about the latest information and resources that The GCS Project provides while deciding on your treatment.   Patients or family members wishing to contact Dr. Birrer for an appointment: Please see the contact information on our GCS Specialists by Location page to ensure reaching his […]


Posted: December 20, 2017 | View More »


Questions for Your Medical Team

Below are some basic questions that you can print and take to your physician’s appointment.   To reach a printable format:     CLICK HERE Information for the Newly Diagnosed Website with information: www.gcsproject.org     Carcinosarcoma Have you treated this diagnosis at this facility? If it’s not common is the treatment common? What chemo drugs […]


Posted: December 22, 2017 | View More »


Scientific Resources – Intro

Here are some articles on uterine carcinosarcoma:   NCCN Guidelines: Uterine Neoplasms, 2017   Uterine Carcinosarcoma, Review of the literature, 2015 – the latest comprehensive review   Arend, Endometrial cancer: Molecular markers and management of advanced stage disease – the article doe not discuss carcinosarcoma, but it addresses the subject of molecular markers.


Posted: November 13, 2017 | View More »


Research and Clinical Trials with Dr. Whitfield Growden (Part 3) [VIDEO]

Patient/advocate Diane Redington and Dr. Whitfield Growden discuss current scientific findings and clinical trials in ovarian and uterine carcinosarcoma. This is part three of a nine-part series. Dr. Growden discusses how they have examined tumors (from Mass General’s tumor bank) of the ovary, uterus, fallopian tubes, and vagina. They found approximately 150 different mutations and […]


Posted: April 20, 2017 | View More »


Diagnosis and Treatment of Gyn Carcinosarcoma (MMMT) with Dr. Whitfield Growden (Part 4) [VIDEO]

Patient/advocate Diane Redington and Dr. Whitfield Growden discuss the management of ovarian and uterine carcinosarcoma. This is part four of a nine-part series. Dr. Growden discusses important differences between ovarian and uterine carcinosarcoma and takes us through the stages and treatment modalities for each at the various stages. Chemotherapy, including intraperitoneal chemotherapy, and radiation is […]


Posted: April 24, 2017 | View More »


Dr. Birrer will stay involved with the GCS Project

Bittersweet News Dr. Birrer is moving from Mass General Cancer Center to become the head of the Comprehensive Cancer Center at the University of Alabama in Birmingham (UAB) as of August 1, 2017. Dr. Birrer remains dedicated to the GCS Project and will launch a GCS Clinic devoted to helping women with gynecological carcinosarcoma obtain […]


Posted: August 8, 2017 | View More »


Research (Part 1) with Dr. Michael Birrer [VIDEO]

Patient/advocate, Diane Redington, and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part one of a nine-part series. Dr. Birrer states that they have already had initial results. They are doing what Dr. Birrer calls a “molecular deep dive”—a technically sophisticated analysis—on a fairly […]


Posted: April 17, 2017 | View More »


Research (Part 2) with Dr. Michael Birrer [VIDEO]

Patient/advocate, Diane Redington and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part two of a nine-part series. Dr. Birrer discusses the fact that doctors typically treat ovarian carcinosarcoma the same as ovarian cancer, but they are NOT the same, and they should not […]


Posted: April 18, 2017 | View More »


How to Find a Clinical Trial with Dr. Whitfield Growden (Part 6) [VIDEO]

Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss availability, eligibility and decisions regarding clinical trials and the differences in treatment options. This is part six of a nine-part series. Dr. Growden explains that carcinosarcomas are generally excluded from clinical trials, although uterine carcinosarcoma has been allowed in some trials. Soon, they are going to be […]


Posted: April 29, 2017 | View More »


Genome Analysis and Immunotherapy with Dr. Whitfield Growden (Part 5) [VIDEO]

Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss genomic analysis, patterns of resistance, and immunotherapy. This is part five of a nine-part series. Dr. Growden discusses tumor specimens used for genomic analysis and the impact of tumor changes. Recognizing patterns of resistance is very important for treatment. Also discussed is a type of immunotherapy called […]


Posted: April 27, 2017 | View More »